Basit öğe kaydını göster

dc.contributor.authorOzguroglu, M.
dc.contributor.authorOudard, S. M.
dc.contributor.authorHansen, S.
dc.contributor.authorDe Bono, J. S.
dc.contributor.authorSartor, A. O.
dc.contributor.authorGupta, S.
dc.contributor.authorShen, L.
dc.contributor.authorMachiels, J.
dc.date.accessioned2021-03-05T18:52:41Z
dc.date.available2021-03-05T18:52:41Z
dc.identifier.citationOudard S. M. , De Bono J. S. , Ozguroglu M., Hansen S., Machiels J., Shen L., Gupta S., Sartor A. O. , "CABAZITAXEL PLUS PREDNISONE/PREDNISOLONE SIGNIFICANTLY INCREASES OVERALL SURVIVAL COMPARED TO MITOXANTRONE PLUS PREDNISONE/PREDNISOLONE IN PATIENTS WITH METASTATIC CASTRATION-RESISTANT PROSTATE CANCER (MCRPC) PREVIOUSLY TREATED WITH DOCETAXEL: FINAL RESULTS WITH UPDATED OVERALL SURVIVAL OF A MULTINATIONAL PHASE III TRIAL (TROPIC)", 35th European-Society-for-Medical-Oncology (ESMO) Congress, Milan, İtalya, 8 - 12 Ekim 2010, cilt.21, ss.272
dc.identifier.othervv_1032021
dc.identifier.otherav_cc8ba220-8fea-494a-9d95-41c28bbcaaf0
dc.identifier.urihttp://hdl.handle.net/20.500.12627/135401
dc.language.isoeng
dc.subjectTıp
dc.subjectDahili Tıp Bilimleri
dc.subjectSağlık Bilimleri
dc.subjectONKOLOJİ
dc.subjectKlinik Tıp
dc.subjectKlinik Tıp (MED)
dc.subjectOnkoloji
dc.subjectİç Hastalıkları
dc.titleCABAZITAXEL PLUS PREDNISONE/PREDNISOLONE SIGNIFICANTLY INCREASES OVERALL SURVIVAL COMPARED TO MITOXANTRONE PLUS PREDNISONE/PREDNISOLONE IN PATIENTS WITH METASTATIC CASTRATION-RESISTANT PROSTATE CANCER (MCRPC) PREVIOUSLY TREATED WITH DOCETAXEL: FINAL RESULTS WITH UPDATED OVERALL SURVIVAL OF A MULTINATIONAL PHASE III TRIAL (TROPIC)
dc.typeBildiri
dc.contributor.departmentAssistance Publique Hopitaux Paris (APHP) , ,
dc.identifier.volume21
dc.contributor.firstauthorID137498


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster